A Study of Food Effect and Esomeprazole on LY4064809 in Healthy Adult Participants
Clinical trial NCT06991179 · COMPLETED
Trial details
- NCT number
- NCT06991179
- Sponsor
- Scorpion Therapeutics, a wholly owned subsidiary of Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-20
- Primary completion
- 2025-09-02
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.